Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Inhibikase Therapeutics, Inc. (IKT)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
16 Aug 2022
Werner Milton H.
President and CEO, Director, Officer, 10% Owner
Inhibikase Therapeutics, Inc.
(IKT)
5,335,433
+0%
5,000
$0.80
$4,000.00
BUY
27 May 2022
Werner Milton H.
President and CEO, Director, Officer, 10% Owner
Inhibikase Therapeutics, Inc.
(IKT)
5,330,433
+0%
5,000
$0.98
$4,880.00
BUY
20 May 2022
Werner Milton H.
President and CEO, Director, Officer, 10% Owner
Inhibikase Therapeutics, Inc.
(IKT)
5,325,433
+0%
10,000
$0.60
$6,000.00
BUY
19 May 2022
FRATTAROLI JOSEPH
Chief Financial Officer, Officer
Inhibikase Therapeutics, Inc.
(IKT)
48,091
+8%
3,948
$0.64
$2,542.51
BUY
17 Nov 2021
Werner Milton H.
President and CEO, Director, Officer, 10% Owner
Inhibikase Therapeutics, Inc.
(IKT)
23,589
+100%
23,589
$1.97
$46,558.14
Home